A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol

Summary

This is a single-center, randomized, double-blind, placebo-controlled, single-ascending-dose study to evaluate the safety and tolerability of the coadministration of up to 6 dose levels of ANS-6637 and EtOH in healthy male moderate alcohol drinkers. The study will include a screening visit, a qualification visit, a Treatment Phase and follow-up.

Timeline

Start

2017-02-27

Primary completion

2017-11-15

Completion

2017-11-15

Drugs

Indications

No indication recorded.